Suchergebnisse - "Janakiram, Murali"

1

Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma

von: Janakiram, Murali

2012, in: Current treatment options in oncology

Wird geladen...
2

New immunotherapies targeting the PD-1 pathway

von: Chinai, Jordan M.

2015, in: Covering the Cover

Wird geladen...
3

Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer

von: Goyal, Amrita

2020, in: Journal of the American Academy of Dermatology

Wird geladen...
4

JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?

von: Liu, Kenneth G.

2016, in: Biomarker Research

Wird geladen...
5

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

von: Abbasi, Ahmed

2020, in: Journal of hematology & oncology

Wird geladen...
6

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

von: Schuster, Stephen J

2021, in: My

Wird geladen...
7

Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

von: Bazarbachi, Abdul-Hamid

2023, in: Clinical hematology international

Wird geladen...
8

Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study

von: Epperla, Narendranath

2022, in: Journal of hematology & oncology

Wird geladen...
9

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

von: Horwitz, Steven

2019, in: Effects of shape functions on flexural–torsional buckling of fixed circular arches

Wird geladen...
10

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

von: Richardson, Paul G

2019, in: My

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!